JNJ
Johnson & Johnson Healthcare - Pharmaceuticals Investor Relations →
Johnson & Johnson (JNJ) closed at $235.37 as of 2026-03-20, trading 48.3% above its 200-week moving average of $158.68. The stock is currently moving closer to the line, down from 52.6% last week. The 14-week RSI sits at 68, indicating neutral momentum.
Trading volume is running at 1.5x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.99 ratio) is neutral — neither side is clearly dominating.
Over the past 3302 weeks of data, JNJ has crossed below its 200-week moving average 33 times. On average, these episodes lasted 14 weeks. Historically, investors who bought JNJ at the start of these episodes saw an average one-year return of +21.9%.
With a market cap of $567.2 billion, JNJ is a large-cap stock. The company generates a free cash flow yield of 2.9%. Return on equity stands at 35.0%, indicating strong profitability. The stock trades at 7.0x book value.
JNJ is a Dividend Aristocrat, having increased its dividend for 25 or more consecutive years. The current yield is 221.00%. The company has been aggressively buying back shares, reducing its share count by 7.9% over the past three years.
Over the past 33.2 years, a hypothetical investment of $100 in JNJ would have grown to $4781, compared to $2683 for the S&P 500. That represents an annualized return of 12.3% vs 10.4% for the index — confirming JNJ as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 4% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: JNJ vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After JNJ Crosses Below the Line?
Across 22 historical episodes, buying JNJ when it crossed below its 200-week moving average produced an average return of +22.2% after 12 months (median +25.0%), compared to +13.4% for the S&P 500 over the same periods. 85% of those episodes were profitable after one year. After 24 months, the average return was +46.5% vs +29.8% for the index.
Each line shows $100 invested at the moment JNJ crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
JNJ has crossed below its 200-week MA 33 times with an average 1-year return of +21.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Dec 1962 | Jan 1963 | 7 | 8.4% | +39.7% | +495655.8% |
| Feb 1963 | Mar 1963 | 2 | 1.1% | +44.9% | +462675.8% |
| Apr 1963 | Apr 1963 | 1 | 0.3% | +36.0% | +462675.8% |
| Jul 1974 | May 1978 | 201 | 30.3% | -8.7% | +37993.1% |
| Oct 1978 | Nov 1978 | 5 | 5.5% | -12.1% | +45716.5% |
| Dec 1978 | Aug 1979 | 35 | 11.8% | +4.9% | +46592.6% |
| Oct 1979 | Nov 1979 | 7 | 9.9% | +22.5% | +49758.2% |
| Feb 1980 | Apr 1980 | 8 | 6.4% | +42.1% | +48194.1% |
| Feb 1984 | Apr 1984 | 8 | 7.8% | +13.4% | +29325.0% |
| Apr 1984 | Jan 1985 | 36 | 22.4% | +25.7% | +27905.8% |
| Jan 1985 | Jan 1985 | 1 | 0.4% | +39.5% | +26984.2% |
| Apr 1993 | Apr 1993 | 1 | 0.2% | -0.5% | +5335.8% |
| Jul 1993 | Aug 1993 | 5 | 8.2% | +14.4% | +5201.0% |
| Sep 1993 | Oct 1993 | 5 | 2.9% | +32.0% | +5231.2% |
| Feb 1994 | May 1994 | 11 | 10.2% | +44.0% | +4923.7% |
| Mar 2000 | Apr 2000 | 1 | 1.2% | +26.2% | +1221.9% |
| Jul 2002 | Jul 2002 | 1 | 12.6% | +28.0% | +976.6% |
| Jul 2003 | Aug 2003 | 1 | 0.1% | +11.7% | +779.7% |
| Aug 2003 | Sep 2003 | 2 | 1.5% | +17.4% | +791.3% |
| Sep 2003 | Nov 2003 | 8 | 3.3% | +18.6% | +777.6% |
| Nov 2003 | Dec 2003 | 4 | 2.5% | +25.0% | +791.4% |
| Jan 2004 | Jan 2004 | 1 | 0.8% | +26.7% | +771.0% |
| Mar 2004 | Apr 2004 | 5 | 2.5% | +35.9% | +762.8% |
| Oct 2008 | Jul 2009 | 40 | 19.9% | +14.3% | +606.6% |
| May 2010 | Jun 2010 | 5 | 1.8% | +18.7% | +544.6% |
| Jul 2010 | Aug 2010 | 6 | 2.2% | +20.0% | +546.2% |
| Mar 2020 | Mar 2020 | 2 | 3.6% | +37.1% | +132.2% |
| Oct 2023 | Nov 2023 | 6 | 5.3% | +11.3% | +65.8% |
| Apr 2024 | Jul 2024 | 15 | 5.5% | +3.8% | +63.8% |
| Nov 2024 | Feb 2025 | 14 | 8.0% | +23.9% | +58.1% |
| Mar 2025 | Apr 2025 | 2 | 1.3% | N/A | +57.9% |
| May 2025 | May 2025 | 2 | 1.6% | N/A | +59.9% |
| Jun 2025 | Jun 2025 | 2 | 1.8% | N/A | +60.1% |
| Average | 14 | — | +21.9% | — |
Frequently Asked Questions
Is JNJ below its 200-week moving average?
No. Johnson & Johnson (JNJ) is currently 48.3% above its 200-week moving average of $158.68. It would need to fall to $158.68 to cross below the line.
What is JNJ's 200-week moving average price?
Johnson & Johnson's 200-week moving average is $158.68 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when JNJ drops below its 200-week moving average?
JNJ has crossed below its 200-week moving average 33 times in our data. On average, buying at that moment produced a one-year return of +21.9%. These dips have historically been decent entry points. These episodes lasted 14 weeks on average.
Is JNJ a good value right now?
Here's what our data says about JNJ as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 68. Free cash flow yield is 2.9%. Return on equity is 35.0%. Price-to-book is 7.0x. This is not a buy or sell recommendation — always do your own research.
How does JNJ compare to the S&P 500?
Over the past 33.2 years, $100 invested in JNJ would have grown to $4781, compared to $2683 for the S&P 500. That's 12.3% annualized vs 10.4% for the index. JNJ has outperformed the broader market over this period.
Does JNJ pay a dividend?
Yes. Johnson & Johnson currently pays a dividend yield of 221.00%. It is also a Dividend Aristocrat, meaning it has raised its dividend for 25 or more consecutive years.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20